Jim Cramer Says This Tech Is 'Just A Rocket Ship, I Know'

United States Antimony (UAMY) secured a significant Indefinite Delivery Indefinite Quantity (IDIQ) sole-source contract valued at up to $245 million from the U.S. Defense Logistics Agency for antimony metal ingots to replenish the National Defense Stockpile, resulting in a 2.2% share increase. Concurrently, Amphenol (APH) received reaffirmed Buy ratings and raised price targets from Goldman Sachs and Citigroup, although its shares saw a 1.3% decline.

Analysis

United States Antimony Corporation (UAMY) has secured a material catalyst through a sole-source Indefinite Delivery Indefinite Quantity (IDIQ) contract with the U.S. Defense Logistics Agency. This contract, valued at up to $245 million for antimony metal ingots, provides significant revenue potential and validates the company's strategic importance in replenishing the National Defense Stockpile, lending substance to Jim Cramer's characterization of it as a "spec that actually makes money." The stock responded positively with a 2.2% gain to $6.39. In contrast, Amphenol Corporation (APH), lauded by Cramer as a "rocket ship," received strong endorsements from sell-side analysts. Goldman Sachs reiterated a Buy rating and increased its price target to $139, while Citigroup also maintained a Buy and lifted its target to $145. Despite this bullish consensus, Amphenol's shares declined 1.3% to $121.01, suggesting a potential short-term disconnect between analyst sentiment and market price action.

Key Decisions for Investors

• Investors should evaluate the U.S. Antimony contract as a fundamental de-risking event, as the potential $245 million in government revenue provides significant visibility for a company previously viewed as speculative.
• The 1.3% decline in Amphenol's shares, occurring despite two price target increases from major banks, may represent a tactical buying opportunity for those confident in the bullish analyst outlook.
• Monitor UAMY for specific delivery orders and revenue recognition under the IDIQ contract, as this will be the key determinant of the contract's actual value realization versus its maximum potential.